Information Library
Enrollment & retention - Patient & Investigator Recruitment
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Hepatitis B Vaccine-Successful Study Strategy in Asia
November 9, 2009
Quintiles helped a customer overcome recruitment and regulatory challenges for a Hepatitis B vaccine study in Asia. -
QUINTILES LAUNCHES CLINICALRESEARCH.COM
September 30, 2009 - Patients who want to play an active role in bringing new, safer drugs to market faster now have access to a global Web site that makes it easier than ever before to identify clinical trials to participate in – regardless of geography or the drug company sponsor. -
Sub-Saharan Africa Phase II/III Fact Sheet
July 29, 2009
Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond. -
For Investigators: Public Perception
July 17, 2009
Find out more about the public perception of clinical trials. -
QUINTILES ANNOUNCES NEW GHANA OFFICE
June 16, 2009 - To improve efficiency and expand capacity to monitor the growing number of clinical studies being conducted in Western Sub-Saharan Africa, Quintiles today announced the opening of a new office in Accra, Ghana. -
Strong Site Relationships Support Rapid Recruitment
March 27, 2009
To conduct a worldwide oncology registration study, a top 10 pharmaceutical company came to a unit of Quintiles in Europe that focuses exclusively on oncology studies. Not only does the department head have 14 years of experience in cancer clinical research, but her 13 project managers were chosen specifically because of their extensive knowledge of how to run global cancer studies. -
Cardiovascular Expertise Results in Faster Enrollment Speed
March 27, 2009
Mega-trials require mega-expertise, especially when the global study is for an innovative cardiovascular drug to treat patients with acute coronary syndrome who have also undergone coronary artery bypass surgery.
Page 1 of 1 (7 items)